摘要
目的探讨双黄连针剂在治疗尘肺引起的慢性阻塞性肺疾病(COPD)急性加重期的疗效。方法选择120例尘肺引起的COPD急性加重期患者,随机分为治疗组和对照组各60例,治疗组在常规治疗的基础上加用双黄连,对照组仅进行常规治疗,比较两组患者的临床疗效。结果两组患者临床疗效间差异有统计学意义(P<0.05)。两组治疗后尿常规、肝肾功能、血电解质、心电图均未见明显异常。结论联合双黄连针剂治疗尘肺引起的COPD急性加重期时疗效明显,治愈率高,改善症状快,不良反应发生率低,安全可靠。
Objective To investigate the therapeutic effect of Shuanghuanglian Injection on pneumoconiosis caused by chronic obstructive pulmonary disease （COPD） during the acute - exacerbated period. Methods 120 cases of pneumoconiosis caused by chronic obstructive pulmonary disease in acute - exacerbated period were randomly divided into treatment group （60 cases） and control groups （60 cases）. The treatment group by the conventional treatment plus Shuanghuanglian Injection while the control group only adopts conventional treatment, then make observation for both groups. Results It showed that 49. 1 percent for the clinical control rate of the treatment group while 38. 3 percent of the control group. Total effective rate in the treatment group was 95.8% and 90. 0% in the control group. Conclusion The apparent high cure rate of pneumoconiosis of chronic obstructive pulmonary disease in the acute- exacerbated period by Shuanghuanglian Injection, and improve the situation quickly with lower chances of side effects, safe and reliable, it was worth to promoting the use among the primary health care units.
出处
《实用心脑肺血管病杂志》
2009年第1期27-28,共2页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词
尘肺
肺疾病
慢性阻塞性
双黄连针剂
Pneumoeoniosis
Pulmonary disease, Chronic obstructive
Shuanghuanglian Injection
